Search clinical trials for: EGFRvIII
Total 26 results
-
Hideho Okada, MD, PhDNational Cancer Institute (NCI); California Institute for Regenerative Medicine...RecruitingGlioblastoma | Recurrent Glioblastoma | EGFR Gene Mutation | MGMT-Unmethylated GlioblastomaUnited States
-
Beijing Tsinghua Chang Gung HospitalBeijing DCTY® Biotech Co.,Ltd.Not yet recruiting
-
Massachusetts General HospitalNot yet recruitingGlioblastoma Recurrent, EGFR vIII Mutant | Newly Diagnosed Glioblastoma, EGFRvIII Mutant | Recurrent Glioblastoma, EGFR vIII NegativeUnited States
-
Duke UniversityNot yet recruitingGlioblastoma | Malignant GliomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingMetastatic Lung Non-Small Cell Carcinoma | Anaplastic Astrocytoma, IDH-Wildtype | Glioblastoma, IDH-Wildtype | Metastatic Malignant Neoplasm in the Central Nervous SystemUnited States
-
Northwell HealthRecruitingGlioblastoma | Brain Cancer | Brain Tumor | GBM | Brain Neoplasm | Brain Neoplasm, Malignant | EGFR Gene OverexpressionUnited States
-
Maastricht Radiation OncologyWithdrawnGlioblastoma | Astrocytoma, Grade IV
-
University of PennsylvaniaCompleted
-
University of PennsylvaniaCompletedSubjects Entering Into This Protocol Will be Followed for up to 15 Years After Initial CART-EGFRvIII InfusionUnited States
-
University of PennsylvaniaUniversity of California, San FranciscoTerminatedPatients With Residual or Reccurent EGFRvIII+ GliomaUnited States
-
AbbVieRadiation Therapy Oncology GroupCompletedGlioblastoma | GliosarcomaUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Colombia, Czechia, France, Germany, Hong Kong, Ireland, Israel, Italy, Korea, Republic of, Mexico, Netherlands, New Zealand, Portugal, Russian Federation, Singapor... and more
-
Daniel LandiTerminatedGlioblastoma | GliosarcomaUnited States
-
AmgenCompletedGlioblastoma or Malignant GliomaUnited States, Australia, Netherlands, Germany, Spain, France
-
Chembrain LTDUniversity of Oulu; Jyväskylä Central Hospital; Apollo Hospital, New Delhi, IndiaActive, not recruitingGlioblastoma | Glioblastoma Multiforme | Glioma, MalignantFinland, India
-
Paul Graham FisherNational Cancer Institute (NCI); National Institutes of Health (NIH)TerminatedBrain Cancer | Pontine Tumors | Brain Stem TumorsUnited States
-
Grupo Español de Investigación en NeurooncologíaPfizerCompleted
-
Gary Archer Ph.D.National Cancer Institute (NCI); Duke Cancer InstituteTerminatedRecurrent Glioblastoma | Recurrent GliosarcomaUnited States
-
Celldex TherapeuticsCompletedGlioblastoma | Gliosarcoma | Recurrent Glioblastoma | Small Cell Glioblastoma | Giant Cell Glioblastoma | Glioblastoma With Oligodendroglial Component | Relapsed GlioblastomaUnited States
-
Maastricht Radiation OncologyCompletedGlioblastoma MultiformeNetherlands
-
National Cancer Institute (NCI)CompletedGlioblastoma | Brain Cancer | Malignant Glioma | GliosarcomaUnited States
-
Celldex TherapeuticsCompletedGlioblastoma | Gliosarcoma | Small Cell Glioblastoma | Giant Cell Glioblastoma | Glioblastoma With Oligodendroglial ComponentUnited States, Canada, Australia, Israel, Taiwan, United Kingdom, Belgium, France, Spain, Germany, Austria, Brazil, Colombia, Czechia, Greece, Hungary, India, Italy, Mexico, Netherlands, New Zealand, Peru, Switzerland, Thailand
-
Celldex TherapeuticsCompletedMalignant GliomaUnited States
-
Northwell HealthCompletedGBM | Anaplastic Astrocytoma | Glioblastoma Multiforme (GBM) | ANAPLASTIC ASTROCYTOMA (AOA)United States
-
Beijing Sanbo Brain HospitalMarino Biotechnology Co., Ltd.UnknownGlioblastoma MultiformeChina
-
AmgenCompletedGlioblastoma Multiforme | Advanced Malignant Glioma | Anaplastic AstrocytomasUnited States, Australia
-
John SampsonNational Cancer Institute (NCI)CompletedMalignant Neoplasms of BrainUnited States